[Efficacy of continuous positive airway pressure therapy upon resistant hypertension in patients with obstructive sleep apnea hypopnea syndrome].
To investigate the efficacy and possible mechanism of continuous positive airway pressure (CPAP) therapy upon blood pressure in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and resistant hypertension (RH). Thirteen OSAHS patients with RH were recruited. Before and after 3-month CPAP therapy, their blood pressures at 10:00 PM, 2:00 AM and 6:00 AM were measured and their morning plasma concentrations of aldosterone (ALD) and plasma renin activity (PRA) tested at supine position with radioimmunoassay. Compared with blood pressure parameters at pre-CPAP therapy, there was a significant decrease in blood pressure before sleep at the end of 3-month CPAP therapy [(135.5 +/- 2.8)/(84.2 +/- 4.6) vs (152.2 +/- 19.2)/(98.9 +/- 15.6) mm Hg, P < 0.01], at night during sleep [ (133.1 +/- 2.4)/(81.5 +/- 4.6) vs (156.6 +/- 19.4)/(102.8 +/- 16.6) mm Hg, P < 0.01] and in the early morning [(151.5 +/- 3.0)/(81.2 +/- 3.2) vs (172.1 +/- 23.7)/(98.1 +/- 6.5) mm Hg, P < 0.01]. Comparison of plasma concentrations of ALD and PRA before and after 3-month CPAP therapy indicated that there was a significant difference in ALD [(538 +/- 42) vs (408 +/- 53) pmol/L, P < 0.01] but not significantly different in PRA [(0.27 +/- 0.14) microg x L(-1) x h(-1) vs (0.20 +/- 0.12), P = 0.221]. CPAP therapy could significantly improve RH and plasma ALD concentration. Elevated plasma ALD concentration is possibly involved in the pathogenesis of RH in OSAHS patients.